EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NGR1 Pretreatment Enhances the Therapeutic Efficacy of Transplanting Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells for Myocardial Infarction

Hao Cai, Meng-Ying Huang, Fang-Fang Mou, Qiang-Li Wang, Zhi-Rong Luo, Ping-Ping Lu, Bao-Nian Liu, Liang Hu, Hai-Dong Guo iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27010475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Hao Cai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Myocardial Infarction, Induced Pluripotent Stem Cells, Saponins. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Traditional Chinese Medicine Research Project of Shanghai Municipal Health Commission, Natural Science Foundation of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human induced pluripotent stem cells (hiPSCs) offer significant potential for differentiation and research applications in cardiovascular diseases. When induced differentiated hiPSC-derived cardiomyocytes (hiPSC-CMs) are transplanted into the infarcted myocardial region, they exhibit extremely low survival rates and unsatisfactory therapeutic effects due to ischemia, hypoxia, and immune inflammation in the surrounding environment. To address this issue, we used Panax notoginseng saponin R1 (NGR1), which has demonstrated significant protective effects in prior research, to pretreat hiPSC-CMs before transplantation. Utilizing an in vitro H2O2 oxidative stress model and a nude mouse myocardial infarction (MI) model, we investigated the mechanism through which NGR1 pretreatment enhances the therapeutic efficacy of hiPSC-CM transplantation. The results revealed that the hiPSC-CMs expressed cTnT. NGR1 did not promote the proliferation of hiPSC-CMs but instead induced elevated levels of p-Akt protein in these cells. Compared to hiPSC-CM transplantation alone, transplantation of hiPSC-CMs pretreated with NGR1 exhibited higher ejection fraction (EF) and fractional shortening (FS) values, along with reduced infarct size and collagen deposition. Additionally, there were more HNA-positive cardiomyocytes in the cardiac tissue, fewer TUNEL-positive signals, and increased VWF-positive and Lyve1-positive signals. Furthermore, the gene expression levels of VEGFC, IGF-1, and SDF-1 were higher. Therefore, NGR1 pretreatment improves the survival of transplanted hiPSC-CMs in tissues, reduces myocardial apoptosis, enhances cardiac function, decreases infarct size and collagen deposition, promotes angiogenesis and lymphangiogenesis, and stimulates paracrine secretion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacMyocardial InfarctionInduced Pluripotent Stem CellsSaponinsHumansAnimalsMiceCell DifferentiationOxidative StressApoptosisMice, NudeMale

Stichwörter der Autor:innen

heart functioninduced pluripotent stem cellmyocardial infarctionparacrine secretionsurvival

Substanzen

Saponins

Autor:innen und Institutionen

  • Department of Anatomy, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Department of Histoembryology, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

ORCID-Profile: Hai-Dong Guo

Förderung

  • National Natural Science Foundation of China
  • Traditional Chinese Medicine Research Project of Shanghai Municipal Health Commission
  • Natural Science Foundation of Shanghai
  • National Natural Science Foundations of China

Zitieren

APA

Cai, H., Huang, M. Y., Mou, F. F., Wang, Q. L., Luo, Z. R., Lu, P. P., Liu, B. N., Hu, L., & Guo, H. D. (2026). NGR1 Pretreatment Enhances the Therapeutic Efficacy of Transplanting Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells for Myocardial Infarction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010475

Vancouver

Cai H, Huang MY, Mou FF, Wang QL, Luo ZR, Lu PP, et al. NGR1 Pretreatment Enhances the Therapeutic Efficacy of Transplanting Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells for Myocardial Infarction. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27010475

BibTeX
@article{Cai2026,
  author = {Cai, Hao and Huang, Meng-Ying and Mou, Fang-Fang and Wang, Qiang-Li and Luo, Zhi-Rong and Lu, Ping-Ping and Liu, Bao-Nian and Hu, Liang and Guo, Hai-Dong},
  title = {NGR1 Pretreatment Enhances the Therapeutic Efficacy of Transplanting Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells for Myocardial Infarction},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27010475}
}
Kostenlos starten →